These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15128615)

  • 1. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
    Fernando KT; McLean MA; Chard DT; MacManus DG; Dalton CM; Miszkiel KA; Gordon RM; Plant GT; Thompson AJ; Miller DH
    Brain; 2004 Jun; 127(Pt 6):1361-9. PubMed ID: 15128615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
    Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.
    Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schild HH; Träber F
    J Neurol; 2008 Jan; 255(1):56-63. PubMed ID: 18080854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.
    Kapeller P; Brex PA; Chard D; Dalton C; Griffin CM; McLean MA; Parker GJ; Thompson AJ; Miller DH
    Mult Scler; 2002 May; 8(3):207-10. PubMed ID: 12120691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; McLean MA; Miller DH; Thompson AJ
    Arch Neurol; 2005 Apr; 62(4):569-73. PubMed ID: 15824254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.
    Brex PA; Gomez-Anson B; Parker GJ; Molyneux PD; Miszkiel KA; Barker GJ; MacManus DG; Davie CA; Plant GT; Miller DH
    J Neurol Sci; 1999 Jun; 166(1):16-22. PubMed ID: 10465494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.
    Kapeller P; Ropele S; Enzinger C; Lahousen T; Strasser-Fuchs S; Schmidt R; Fazekas F
    J Neurol; 2005 Oct; 252(10):1229-34. PubMed ID: 15895306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
    John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
    J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
    Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
    J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
    Tisell A; Leinhard OD; Warntjes JB; Aalto A; Smedby Ö; Landtblom AM; Lundberg P
    PLoS One; 2013; 8(4):e61817. PubMed ID: 23613944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
    Vrenken H; Barkhof F; Uitdehaag BM; Castelijns JA; Polman CH; Pouwels PJ
    Magn Reson Med; 2005 Feb; 53(2):256-66. PubMed ID: 15678547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis.
    Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schmidt S; Schild HH; Träber F
    Neuroradiology; 2008 Feb; 50(2):123-9. PubMed ID: 17982745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
    Cucurella MG; Rovira A; Río J; Pedraza S; Tintoré MM; Montalbán X; Alonso J
    NMR Biomed; 2000 Apr; 13(2):57-63. PubMed ID: 10797633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.
    Oguz KK; Kurne A; Aksu AO; Karabulut E; Serdaroglu A; Teber S; Haspolat S; Senbil N; Kurul S; Anlar B
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):716-21. PubMed ID: 19147724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
    Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
    Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
    PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
    Gustafsson MC; Dahlqvist O; Jaworski J; Lundberg P; Landtblom AM
    AJNR Am J Neuroradiol; 2007 Aug; 28(7):1306-12. PubMed ID: 17698533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.